invasive ductal carcinoma

Common Name(s)

invasive ductal carcinoma, invasive ductal carcinoma, breast cancer

Invasive ductal carcinoma (IDC) is the most common type of breast cancer. IDC begins in the milk duct of the breast and spreads through the wall of the duct into the breast tissue. These cancerous cells also have the ability to spread to other parts of the body.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "invasive ductal carcinoma" for support, advocacy or research.

Logo
Breast Cancer Connections

We support people touched by breast or ovarian cancer by providing comprehensive, personalized services in an atmosphere of warmth and compassion.

Last Updated: 22 Apr 2014

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "invasive ductal carcinoma" for support, advocacy or research.

Logo
Breast Cancer Connections

We support people touched by breast or ovarian cancer by providing comprehensive, personalized services in an atmosphere of warmth and compassion.

http://www.bcconnections.org

Last Updated: 22 Apr 2014

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "invasive ductal carcinoma" returned 178 free, full-text research articles on human participants. First 3 results:

[Triexponential diffusion analysis in invasive ductal carcinoma and fibroadenoma].
 

Author(s): Masayuki Nakagawa, Tosiaki Miyati, Tatsuya Hayashi, Syotaro Kanao, Masahiro Taniguchi, Kyoji Higashimura, Masakazu Toi, Kaori Togashi

Journal: Nihon Hoshasen Gijutsu Gakkai Zasshi. 2014 Mar;70(3):199-205.

 

To simultaneously obtain information on diffusion and perfusion in breast lesions by diffusion-weighted magnetic resonance imaging (DWI), we analyzed three diffusion components using a triexponential function. Eighteen subjects [10 with invasive ductal carcinoma (IDC), 8 with fibroadenoma] ...

Last Updated: 20 Mar 2014

Go To URL
An N-terminal splice variant of human Stat5a that interacts with different transcription factors is the dominant form expressed in invasive ductal carcinoma.
 

Author(s): Dunyong Tan, KuanHui E Chen, Changhui Deng, Peizhi Tang, Jianjun Huang, Trina Mansour, Richard A Luben, Ameae M Walker

Journal: Cancer Lett.. 2014 Apr;346(1):148-57.

 

We have identified a new variant of human Stat5a, found at higher ratios to full-length Stat5a in invasive ductal carcinoma versus contiguous normal tissue. The variant, missing exon 5, inhibits p21 and Bax production and increases cell number. After prolactin stimulation, only full-length ...

Last Updated: 5 Mar 2014

Go To URL
Prognostic significance of RSPO1, WNT1, P16, WT1, and SDC1 expressions in invasive ductal carcinoma of the breast.
 

Author(s): Eun Ji Choi, Jeong A Yun, Eun Kyoung Jeon, Hye Sung Won, Yoon Ho Ko, Su Young Kim

Journal:

 

To better understand the mechanisms of the SDC1 expression in invasive ductal carcinoma, we studied the correlations between SDC1 expression and related gene expressions (RSPO1, WNT1, WT1, and P16).

Last Updated: 3 Jan 2014

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "invasive ductal carcinoma" returned 5 free, full-text review articles on human participants. First 3 results:

A systematic review to establish the frequency of cyclooxygenase-2 expression in normal breast epithelium, ductal carcinoma in situ, microinvasive carcinoma of the breast and invasive breast cancer.
 

Author(s): J A Glover, C M Hughes, M M Cantwell, L J Murray

Journal: Br. J. Cancer. 2011 Jun;105(1):13-7.

 

Epidemiological studies have suggested a protective effect of cyclooxygenase (COX)-inhibiting non-steroidal anti-inflammatory drugs in breast cancer risk and disease progression. We performed a systematic review to evaluate the frequency of COX-2 expression in normal breast epithelium, ...

Last Updated: 29 Jun 2011

Go To URL
Invasive ductal carcinoma in a mammary hamartoma: case report and review of the literature.
 

Author(s): Nami Choi, Eun Sook Ko

Journal: Korean J Radiol. ;11(6):687-91.

 

Mammary hamartomas are typically a benign condition and rarely develop into malignant lesions. Only 14 cases of carcinomas associated with a hamartoma have been documented in the literature. In this case report, we describe a case of invasive ductal carcinoma within a hamartoma in ...

Last Updated: 15 Nov 2010

Go To URL
The molecular journey from ductal carcinoma in situ to invasive breast cancer.
 

Author(s): Lisa Wiechmann, Henry M Kuerer

Journal: Cancer. 2008 May;112(10):2130-42.

 

Ductal carcinoma in situ (DCIS) accounts for approximately 20% of mammographically detected breast cancers. DCIS can recur or progress to invasive breast cancer, but the ability to predict the outcome of patients with DCIS remains limited, leading to inappropriate treatment choices. ...

Last Updated: 5 May 2008

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer
 

Status: Not yet recruiting

Condition Summary: Ductal Breast Carcinoma in Situ; Estrogen Receptor-negative Breast Cancer; Estrogen Receptor-positive Breast Cancer; Invasive Ductal Breast Carcinoma; Invasive Ductal Breast Carcinoma With Predominant Intraductal Component; Lobular Breast Carcinoma in Situ; Medullary Ductal Breast Carcinoma With Lymphocytic Infiltrate; Mucinous Ductal Breast Carcinoma; Papillary Ductal Breast Carcinoma; Progesterone Receptor-positive Breast Cancer; Stage IA Breast Cancer; Stage IB Breast Cancer; Tubular Ductal Breast Carcinoma

 

Last Updated: 7 Jul 2014

Go to URL
Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer
 

Status: Recruiting

Condition Summary: Inflammatory Breast Cancer; Invasive Ductal Breast Carcinoma; Invasive Lobular Breast Carcinoma; Mucinous Ductal Breast Carcinoma; Papillary Ductal Breast Carcinoma; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Tubular Ductal Breast Carcinoma

 

Last Updated: 30 Apr 2014

Go to URL
Intraoperative Imaging of Breast Cancer With Indocyanine Green
 

Status: Recruiting

Condition Summary: Invasive Ductal Carcinoma; Invasive Lobular Carcinoma; Ductal Carcinoma

 

Last Updated: 21 May 2014

Go to URL